good and badI read both good and bad in ONC's job posting:
Good because ONC needs more employees to at least give
the appearance of being more credible (take a look at
the number of employees and job postings for CEGE). I
think both potential investors and potential partners
might be a little concerned that ONC is not busier...
BAD because ONC was very seriously hoping for a human
partnership this fall and felt there was a strong possiblity
that the partner would be running the phase 2 trials. This
posting appears to be an admission that a partnership is far
away.
Also... someone please explain why ONC cannot provide at least
a little news for us (eg. 5 of 6 cohorts finished). Anything
would be nice! If Brad has a genuine concern for his 9000+
shareholders, shouldn't he offer us something?